Postdoc start-up grant: Obesity as an epigenetic modifier of doxorubicin-induced cardiotoxicity
| Institution | Universität Heidelberg |
|---|---|
| Project leader | Daniel Finke |
| Site | Heidelberg/Mannheim |
| Project type | Exzellenzprogramm |
| Funding | € 84.831,33 |
| Begin | 01.04.2025 |
| End | 31.03.2027 |
Förderkennzeichen
81X3500149
Projektnummer
1957